2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide

C126H164N28O22S — CID 160951441

About 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide

2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide (PubChem CID 160951441) has the molecular formula C126H164N28O22S and a molecular weight of 2454.94 g/mol. Its IUPAC name is 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide.

Molecular Properties

• Compound Name: 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide
• PubChem CID: 160951441
• Molecular Formula: C126H164N28O22S
• Molecular Weight: 2454.94 g/mol
• Exact Mass: 2453.23
• IUPAC Name: 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide
• SMILES: CC(C)C1c2nc(C(=O)NO)cn2CCN1C(=O)C1CCN(C)CC1.CC(C)C1c2nc(C(=O)NO)cn2CCN1C(=O)c1ccc(-c2ccccc2)cc1.CC1(C)CN(C(=O)C23CC4CC(CC(C4)C2)C3)Cc2cc(C(=O)NO)cn2C1.CC1(C)CN(C(=O)CC2CCCC2)Cc2cc(C(=O)NO)cn2C1.CC1c2nc(C(=O)NO)cn2CCN1C(=O)c1cccn1C.CCCS(=O)(=O)N1CCn2cc(C(=O)NO)cc2C1CC.O=C(NO)c1nc2n(n1)CCN(C(=O)c1ccc(-c3ccccc3)cc1)C2
• InChI: InChI=1S/C23H24N4O3.C22H31N3O3.C19H17N5O3.C18H27N3O3.C17H27N5O3.C14H17N5O3.C13H21N3O4S/c1-15(2)20-21-24-19(22(28)25-30)14-26(21)12-13-27(20)23(29)18-10-8-17(9-11-18)16-6-4-3-5-7-16;1-21(2)12-24-10-17(19(26)23-28)6-18(24)11-25(13-21)20(27)22-7-14-3-15(8-22)5-16(4-14)9-22;25-18(22-27)17-20-16-12-23(10-11-24(16)21-17)19(26)15-8-6-14(7-9-15)13-4-2-1-3-5-13;1-18(2)11-20-9-14(17(23)19-24)8-15(20)10-21(12-18)16(22)7-13-5-3-4-6-13;1-11(2)14-15-18-13(16(23)19-25)10-21(15)8-9-22(14)17(24)12-4-6-20(3)7-5-12;1-9-12-15-10(13(20)16-22)8-18(12)6-7-19(9)14(21)11-4-3-5-17(11)2;1-3-7-21(19,20)16-6-5-15-9-10(13(17)14-18)8-12(15)11(16)4-2/h3-11,14-15,20,30H,12-13H2,1-2H3,(H,25,28);6,10,14-16,28H,3-5,7-9,11-13H2,1-2H3,(H,23,26);1-9,27H,10-12H2,(H,22,25);8-9,13,24H,3-7,10-12H2,1-2H3,(H,19,23);10-12,14,25H,4-9H2,1-3H3,(H,19,23);3-5,8-9,22H,6-7H2,1-2H3,(H,16,20);8-9,11,18H,3-7H2,1-2H3,(H,14,17)
• InChIKey: SVUVCKQKNDKGCQ-UHFFFAOYSA-N
• XLogP: 13.54
• TPSA: 611.68 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 36
• Rotatable Bonds: 22
• Heavy Atoms: 177
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2454.94
LogP ≤ 5	13.54
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	36

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide?

The IUPAC name of 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide (CID 160951441) is 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide.

What is the SMILES notation for 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide?

The canonical SMILES for 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide is CC(C)C1c2nc(C(=O)NO)cn2CCN1C(=O)C1CCN(C)CC1.CC(C)C1c2nc(C(=O)NO)cn2CCN1C(=O)c1ccc(-c2ccccc2)cc1.CC1(C)CN(C(=O)C23CC4CC(CC(C4)C2)C3)Cc2cc(C(=O)NO)cn2C1.CC1(C)CN(C(=O)CC2CCCC2)Cc2cc(C(=O)NO)cn2C1.CC1c2nc(C(=O)NO)cn2CCN1C(=O)c1cccn1C.CCCS(=O)(=O)N1CCn2cc(C(=O)NO)cc2C1CC.O=C(NO)c1nc2n(n1)CCN(C(=O)c1ccc(-c3ccccc3)cc1)C2.

What is the InChIKey of 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide?

The InChIKey is SVUVCKQKNDKGCQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24N4O3.C22H31N3O3.C19H17N5O3.C18H27N3O3.C17H27N5O3.C14H17N5O3.C13H21N3O4S/c1-15(2)20-21-24-19(22(28)25-30)14-26(21)12-13-27(20)23(29)18-10-8-17(9-11-18)16-6-4-3-5-7-16;1-21(2)12-24-10-17(19(26)23-28)6-18(24)11-25(13-21)20(27)22-7-14-3-15(8-22)5-16(4-14)9-22;25-18(22-27)17-20-16-12-23(10-11-24(16)21-17)19(26)15-8-6-14(7-9-15)13-4-2-1-3-5-13;1-18(2)11-20-9-14(17(23)19-24)8-15(20)10-21(12-18)16(22)7-13-5-3-4-6-13;1-11(2)14-15-18-13(16(23)19-25)10-21(15)8-9-22(14)17(24)12-4-6-20(3)7-5-12;1-9-12-15-10(13(20)16-22)8-18(12)6-7-19(9)14(21)11-4-3-5-17(11)2;1-3-7-21(19,20)16-6-5-15-9-10(13(17)14-18)8-12(15)11(16)4-2/h3-11,14-15,20,30H,12-13H2,1-2H3,(H,25,28);6,10,14-16,28H,3-5,7-9,11-13H2,1-2H3,(H,23,26);1-9,27H,10-12H2,(H,22,25);8-9,13,24H,3-7,10-12H2,1-2H3,(H,19,23);10-12,14,25H,4-9H2,1-3H3,(H,19,23);3-5,8-9,22H,6-7H2,1-2H3,(H,16,20);8-9,11,18H,3-7H2,1-2H3,(H,14,17).

What are the key properties of 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide?

2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide has a molecular weight of 2454.94 g/mol, XLogP of 13.54, 22 rotatable bonds, 14 hydrogen bond donors, and 36 hydrogen bond acceptors.

Where does this data come from?

All data for 2-(adamantane-1-carbonyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-(2-cyclopentylacetyl)-N-hydroxy-4,4-dimethyl-3,5-dihydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carboxamide;1-ethyl-N-hydroxy-2-propylsulfonyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(1-methylpiperidine-4-carbonyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine-2-carboxamide;N-hydroxy-7-(4-phenylbenzoyl)-8-propan-2-yl-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide is sourced from PubChem (CID 160951441), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).